R R Ali Selected Research

Phosphorothioate Oligonucleotides

1/2003

Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R R Ali Research Topics

Disease

13	Retinal Degeneration 01/2022 - 03/2001
7	Blindness (Hysterical Blindness) 10/2016 - 03/2002
4	Retinal Dystrophies 02/2012 - 06/2001
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2010 - 10/2001
2	Uveitis 12/2012 - 11/2008
2	Cicatrix (Scar) 01/2012 - 01/2003
2	Retinal Diseases 12/2010 - 06/2006
2	Inflammation (Inflammations) 08/2006 - 08/2003
2	Infections 09/2001 - 08/2001
1	type 2 Amaurosis congenita of Leber 05/2013
1	congenital stationary Night blindness 05/2012
1	Leber Congenital Amaurosis 12/2010
1	Herpes Zoster 01/2010
1	Microphthalmos 07/2008
1	Macular Degeneration (Age-Related Maculopathy) 08/2006
1	Rabies (Hydrophobia) 03/2006
1	Wounds and Injuries (Trauma) 03/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2006
1	Hemophilia B (Haemophilia B) 01/2006
1	Blister (Bulla) 08/2003
1	Choroidal Neovascularization 06/2003
1	Hypoxia (Hypoxemia) 06/2003
1	Glaucoma 01/2003

Drug/Important Bio-Agent (IBA)

12	Retinaldehyde (Retinal)IBA 09/2011 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 02/2016 - 08/2003
2	Interleukin-10 (Interleukin 10)IBA 12/2012 - 11/2008
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2012 - 11/2008
2	Ciliary Neurotrophic Factor (CNTF)IBA 01/2012 - 03/2003
2	c-Mer Tyrosine KinaseIBA 08/2006 - 06/2006
2	Nerve Growth Factors (Neurotrophins)IBA 03/2003 - 03/2001
1	Aggrecans (Aggrecan)IBA 01/2022
1	Versicans (Versican)IBA 01/2022
1	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2022
1	Proteoglycans (Proteoglycan)IBA 01/2022
1	ChondroitinIBA 01/2022
1	NeurocanIBA 01/2022
1	Complementary DNA (cDNA)IBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012
1	alpha-MSHIBA 12/2012
1	Interferon-alpha (Interferon Alfa)IBA 12/2012
1	OccludinIBA 01/2010
1	EndotoxinsIBA 11/2008
1	InterleukinsIBA 11/2008
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2008
1	Retinal Pigments (Pigments, Visual)IBA 08/2006
1	AngiostatinsIBA 08/2006
1	EndostatinsIBA 08/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2006
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2006
1	Prednisolone (Predate)FDA LinkGeneric 03/2005
1	ElementsIBA 06/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2003
1	Antisense OligonucleotidesIBA 01/2003
1	Phosphorothioate OligonucleotidesIBA 01/2003
1	PeripherinsIBA 10/2001
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2001
1	bafilomycin AIBA 09/2001
1	DNA (Deoxyribonucleic Acid)IBA 08/2001
1	beta-Galactosidase (Lactaid)IBA 03/2001

Therapy/Procedure

8	Therapeutics 05/2013 - 06/2001
3	Transplantation 10/2016 - 12/2010
1	Cell Transplantation 05/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2009
1	Lasers (Laser) 06/2003
1	Operative Surgical Procedures 01/2003